Collagenase Clostridium Histolyticum in the Treatment of Urologic Disease: Current and Future Impact

Mandl, 1953, Isolation and characterization of proteinase and collagenase from Cl. histolyticum, J Clin Invest, 32, 1323, 10.1172/JCI102861 Starkweather, 1996, Collagenase in the treatment of Dupuytren's disease: an in vitro study, J Hand Surg Am, 21, 490, 10.1016/S0363-5023(96)80368-6 Nyberg, 1982, Identification of an inherited form of Peyronie's disease with autosomal dominant inheritance and association with Dupuytren's contracture and histocompatibility B7 cross-reacting antigens, J Urol, 128, 48 Ralph, 1997, The genetic and bacteriological aspects of Peyronie's disease, J Urol, 157, 291 Gelbard, 1982, Collagenase for Peyronie's disease experimental studies, Urol Res, 10, 135, 10.1007/BF00255956 2016 Mookhtiar, 1992, Clostridium histolyticum collagenases: a new look at some old enzymes, Matrix Suppl, 1, 116 Van Wart, 1985, Complementary substrate specificities of class I and class II collagenases from Clostridium histolyticum, Biochemistry, 24, 6520, 10.1021/bi00344a032 French, 1987, Limited proteolysis of type I collagen at hyperreactive sites by class I and II Clostridium histolyticum collagenases: complementary digestion patterns, Biochemistry, 10, 681, 10.1021/bi00377a004 Gelbard, 1985, The use of collagenase in the treatment of Peyronie's disease, J Urol, 134, 280 Palmieri, 2009, A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie's disease, Eur Urol, 56, 363, 10.1016/j.eururo.2009.05.012 Levine, 2014 2011 Garvin, 1974, Toxicity of collagenase: the relation to enzyme therapy of disk herniation, Clin Orthop Relat Res, 101, 286 Schwarzer, 2001, The prevalence of Peyronie's disease: results of a large survey, BJU Int, 88, 727, 10.1046/j.1464-4096.2001.02436.x Mulhall, 2004, Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening, J Urol, 171, 2350 El-Sakka, 1997, Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression, J Urol, 158, 1391 Jack, 2005, Conservative management options for Peyronie's disease, Curr Urol Rep, 6, 454, 10.1007/s11934-005-0041-2 Carrieri, 1998, A case-control study on risk factors for Peyronie's disease, J Clin Epidemiol, 51, 511, 10.1016/S0895-4356(98)00015-8 Rhoden, 2010, A cross-sectional study for the analysis of clinical, sexual and laboratory conditions associated to Peyronie's disease, J Sex Med, 7, 1529 Jordan, 2007, Peyronie's disease, 792 Chilton, 1982, Factors associated in the aetiology of peyronie's disease, Br J Urol, 54, 748, 10.1111/j.1464-410X.1982.tb13640.x Mulhall, 2006, An analysis of the natural history of Peyronie's disease, J Urol, 175, 2115 Berookhim, 2014, Deformity stabilization and improvement in men with untreated Peyronie's disease, BJU Int, 113, 133, 10.1111/bju.12346 Pryor, 1983, Controlled clinical trial of vitamin E in Peyronie's disease, Prog Reprod Biol Med, 9, 41 Teloken, 1999, Tamoxifen versus placebo in the treatment of Peyronie's disease, J Urol, 162, 2003 Prieto Castro, 2003, Combined treatment with vitamin E and colchicine in the early stages of Peyronie's disease, BJU Int, 91, 522, 10.1046/j.1464-410X.2003.04134.x Biagiotti, 2001, Acetyl-L-carnitine vs tamoxifen in the oral therapy of Peyronie's disease: a preliminary report, BJU Int, 88, 63, 10.1046/j.1464-410x.2001.02241.x Weidner, 2005, Potassium paraaminobenzoate (POTABA) in the treatment of Peyronie's disease: a prospective, placebo-controlled, randomized study, Eur Urol, 47, 530, 10.1016/j.eururo.2004.12.022 Smith, 2011, Pentoxifylline treatment and penile calcifications in men with Peyronie's disease, Asian J Androl, 13, 322, 10.1038/aja.2010.117 Chung, 2016, Evidence-based management guidelines on Peyronie's disease, J Sex Med, 13, 905 Nehra, 2015, American Urological Association Education and Research. Peyronie's disease: AUA guideline, J Urol, 194, 745 Levine, 2003, Tunica albuginea tissue analysis after electromotive drug administration, J Urol, 169, 1775 Fitch, 2007, Topical verapamil HCl, topical trifluoperazine, and topical magnesium sulfate for the treatment of Peyronie's disease—a placebo-controlled pilot study, J Sex Med, 4, 477 Greenfield, 2007, Verapamil versus saline in electromotive drug administration for Peyronie's disease: a double-blind, placebo controlled trial, J Urol, 177, 972 Hauck, 2004, Extracorporeal shock wave therapy for Peyronie's disease: exploratory meta-analysis of clinical trials, J Urol, 171, 740 Müller, 2008, The impact of shock wave therapy at varied energy and dose levels on functional and structural changes in erectile tissue, Eur Urol, 53, 635, 10.1016/j.eururo.2007.06.032 Russell, 2007, Systematic evidence-based analysis of plaque injection therapy for Peyronie's disease, Eur Urol, 51, 640, 10.1016/j.eururo.2006.10.042 Hellstrom, 2006, Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon α-2b for minimally invasive treatment for Peyronie's disease, J Urol, 176, 394 Inal, 2006, Effect of intralesional interferon-alpha 2b combined with oral vitamin E for treatment of early stage Peyronie's disease: a randomized and prospective study, Urology, 67, 1038, 10.1016/j.urology.2005.11.005 Nicolai, 1998, Intralesional verapamil injection versus placebo in Peyronie's disease, J Urol, 159, 117 Rehman, 1998, Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study, Urology, 51, 620, 10.1016/S0090-4295(97)00700-0 Wolff, 2015, Intralesional injections for early Peyronie disease: standardized assessment and analysis of predictive factors for treatment response, Urology, 86, 57, 10.1016/j.urology.2015.03.010 Shirazi, 2009, Effect of intralesional verapamil for treatment of Peyronie's disease: a randomized single-blind, placebo-controlled study, Int Urol Nephrol, 41, 467, 10.1007/s11255-009-9522-4 Peak, 2015, Role of collagenase clostridium histolyticum in Peyronie's disease, Biologics, 9, 107 Dean, 2004, Peyronie's disease: advancements in recent surgical techniques, Curr Opin Urol, 14, 339, 10.1097/00042307-200411000-00008 Levine, 1997, A surgical algorithm for the treatment of Peyronie's disease, J Urol, 158, 2149 Gelbard, 1985, The use of collagenase in the treatment of Peyronie's disease, J Urol, 134, 280 Gelbard, 1993, Collagenase versus placebo in the treatment of Peyronie's disease: a double-blind study, J Urol, 149, 56 Jordan, 2008, The use of intralesional clostridial collagenase injection therapy for Peyronie's disease: a prospective, single-center, non-placebo-controlled study, J Sex Med, 5, 180 Gelbard, 2012, Phase 2b study of the clinical efficacy and safety of collagenase clostridium histolyticum in patients with Peyronie disease, J Urol, 187, 2268 Gelbard, 2013, Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of Peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies, J Urol, 190, 199 Levine, 2015, Clinical safety and effectiveness of collagenase Clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study, J Sex Med, 12, 248 Ziegelmann, 2016, Restoration of penile function and patient satisfaction with intralesional collagenase Clostridium histolyticum injection for Peyronie's disease, J Urol, 195, 1051 Yang, 2016, Peyronie's disease and injectable collagenase Clostridium histolyticum: safety, efficacy, and improvements in subjective symptoms, Urology, 94, 143, 10.1016/j.urology.2016.04.049 Anaissie, 2017, Impact of number of cycles of collagenase Clostridium histolyticum on outcomes in patients with Peyronie's disease, J Urol, 100, 125 Yafi, 2015, Comparative analysis of tunical plication vs. intralesional injection therapy for ventral Peyronie's disease, J Sex Med, 12, 2492 Stewart, 2015, Intralesional injection of interferon-alpha2b improves penile curvature in men with Peyronie's disease independent of plaque location, J Urol, 194, 1704 Milam D. Positive results with collagenase Clostridium histolyticum treatment in two patients with ventral penile curvature due to Peyronie's disease [abstract 116]. Presented at: 21st Annual Fall Meeting of the Sexual Medicine Society of North America. 2015. Las Vegas, Nevada, November 19-22, 2015. Yafi, 2017, Review of management options for patients with atypical Peyronie's disease, Sex Med Rev, 5, 211, 10.1016/j.sxmr.2016.07.004 Santucci, 2007, Male urethral stricture disease, J Urol, 177, 1667 Alwaal, 2014, Epidemiology of urethral strictures, Transl Androl Urol, 3, 209 Palminteri, 2013, Contemporary urethral stricture characteristics in the developed world, Urology, 81, 191, 10.1016/j.urology.2012.08.062 Cavalcanti, 2007, A morphometric analysis of bulbar urethral strictures, BJU Int, 100, 397, 10.1111/j.1464-410X.2007.06904.x Da-Silva, 2002, Extracellular matrix changes in urethral stricture disease, J Urol, 168, 805 Barbagli, 2009, Clinical outcome and quality of life assessment in patients treated with perineal urethrostomy for anterior urethral stricture disease, J Urol, 182, 548 Veeratterapillay, 2012, Long-term effect of urethral dilatation and internal urethrotomy for urethral strictures, Curr Opin Urol, 22, 467, 10.1097/MOU.0b013e32835621a2 Albers, 1996, Long-term results of internal urethrotomy, J Urol, 156, 1611 Pansadoro, 1996, Internal urethrotomy in the management of anterior urethral strictures: long-term follow-up, J Urol, 156, 73 Meeks, 2009, Stricture recurrence after urethroplasty: a systematic review, J Urol, 182, 1266 Wessells, 2017, Male urethral stricture: American Urological Association guideline, J Urol, 197, 182 Pimentel, 1995, Role of angiotensin II in the expression and regulation of transforming growth factor-beta in obstructive nephropathy, Kidney Int, 48, 1233, 10.1038/ki.1995.407 McCoy, 1980, In vitro inhibition of cell growth, collagen synthesis, and prolyl hydroxylase activity by triamcinolone acetonide, Proc Soc Exp Biol Med, 163, 216, 10.3181/00379727-163-40750 Zhang, 2014, Efficacy and safety of local steroids for urethral strictures: a systematic review and meta-analysis, J Endourol, 28, 962, 10.1089/end.2014.0090 Mazdak, 2007, Effect of mitomycin C on anterior urethral stricture recurrence after internal urethrotomy, Eur Urol, 51, 1089, 10.1016/j.eururo.2006.11.038 Somers, 1989, Isolation and characterization of collagen in Peyronie's disease, J Urol, 141, 629 Sangkum, 2015, Collagenase Clostridium histolyticum (Xiaflex) for the treatment of urethral stricture disease in a rat model of urethral fibrosis, Urology, 86, 647.e1, 10.1016/j.urology.2015.06.013 Wiegand